HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
MDXG
Mimedx Group Inc
Healthcare Biotechnology · Georgia, USA · Reports in usd
Market Cap: $499.2M
Market Cap
$499.2M
Enterprise Val
$357.0M
P/E Ratio
16.26
P/B Ratio
2.05
Trailing PEG (1Y)
-0.07
As Of
Apr 29, 2026

Overview & Key Metrics

Reporting period: Mar 31, 2026 · Q1 2026
Book Value$242.9M
Gross Margin70.56%
Profit Margin70.56%
Return on Equity12.86%
Return on Assets9.73%
Current Ratio5.39
Debt/Equity0.07
LT Debt/Equity0.07
Revenue Per Share0.40

Income Statement

Mar 31, 2026
Revenue$59.0M
Cost of Revenue$17.4M
Gross Profit$41.6M
R&D$4.1M
SG&A$53.2M
Operating Expenses$57.8M
Operating Income-$16.2M
Interest Expense$0.00
Tax Expense-$4.5M
Net Income-$10.9M
EPS (Basic)$-0.07
EPS (Diluted)$-0.07
EBIT-$15.3M
EBITDA-$13.4M
Consolidated Income-$10.9M
Non-Controlling Interests$0.00

Balance Sheet

Mar 31, 2026
Cash & Equivalents$159.8M
Accounts Receivable$46.0M
Inventory$26.2M
Current Assets$240.3M
LT Investments$0.00
Property, Plant & Equipment$4.8M
Intangibles$32.6M
Non-Current Assets$68.4M
Total Assets$308.7M
Accounts Payable$11.5M
Current Debt$1.5M
Current Liabilities$44.6M
LT Debt$16.1M
Non-Current Liabilities$21.2M
Total Liabilities$65.7M
Total Debt$17.6M
Retained Earnings-$53.5M
Shareholder Equity$242.9M
Shares Outstanding148,566,586

Cash Flow Statement

Mar 31, 2026
Operating Cash Flow$1.9M
Investing Cash Flow-$5.6M
Financing Cash Flow-$2.6M
CapEx-$570.0K
Free Cash Flow$1.3M
Depreciation & Amort.$1.9M
Stock-Based Comp-$1.7M
Acquisitions / Disposals-$5.0M
Investment Activity$0.00
Debt Issued/Repaid-$375.0K
Equity Issued/Repaid-$1.9M
Dividends Paid$0.00
Net Change in Cash-$6.3M
Data cached · Meta live · Daily live · Statements live · TTL 24h